medisteminc.com
Bize Ulaşın
Şirket hakkında
MediStem was founded in 2005 to develop, acquire and commercialize adult stem cell based therapeutic products. The company currently has 16 families of patent applications, Numerous scientific publications, and has out-licensed certain technologies to generate revenue. Medistem’s main candidate, the Endometrial Regenerative Cell is a universal donor pluripotent stem cell, currently being developed for an advanced form of peripheral artery disease called critical limb ischemia.
US
Bilinmeyen
Doğrulanmamış şirket
iş şeffaflığı
- Şirket bilgileri doğrulanmadı
- Müşterilerinden inceleme isteyin
- Olumsuz yorumlara cevap vermedi